Literature DB >> 27306870

Short-Term Screening Assays for the Identification of Therapeutics for Cancer.

Deborah E Citrin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27306870      PMCID： PMC6349361          DOI： 10.1158/0008-5472.CAN-16-1299

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  DOSE RATE: ITS EFFECT ON THE SURVIVAL OF HELA CELLS IRRADIATED WITH GAMMA RAYS.

Authors:  E J HALL; J S BEDFORD
Journal:  Radiat Res       Date:  1964-06       Impact factor: 2.841

2.  The influence of oxygen and peroxides on the response of mammalian cells and tissues to ionizing radiations.

Authors:  L H GRAY; H B CHASE; E E DESCHNER; J W HUNT; O C SCOTT
Journal:  Prog Nucl Energy 6 Biol Sci       Date:  1959

3.  A RAPID METHOD FOR VIABLE CELL TITRATION AND CLONE PRODUCTION WITH HELA CELLS IN TISSUE CULTURE: THE USE OF X-IRRADIATED CELLS TO SUPPLY CONDITIONING FACTORS.

Authors:  T T Puck; P I Marcus
Journal:  Proc Natl Acad Sci U S A       Date:  1955-07-15       Impact factor: 11.205

4.  Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.

Authors:  Qi Liu; Meng Wang; Ashley M Kern; Saman Khaled; Jing Han; Beow Y Yeap; Theodore S Hong; Jeff Settleman; Cyril H Benes; Kathryn D Held; Jason A Efstathiou; Henning Willers
Journal:  Mol Cancer Res       Date:  2015-02-09       Impact factor: 5.852

5.  Comparison of in vitro methods to determine drug-induced cell lethality.

Authors:  P R Roper; B Drewinko
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

Review 6.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  In vitro and in vivo radiation sensitization of human tumor cells by a novel checkpoint kinase inhibitor, AZD7762.

Authors:  James B Mitchell; Rajani Choudhuri; Kristin Fabre; Anastasia L Sowers; Deborah Citrin; Sonya D Zabludoff; John A Cook
Journal:  Clin Cancer Res       Date:  2010-03-16       Impact factor: 12.531

Review 8.  Altering the response to radiation: sensitizers and protectors.

Authors:  Deborah E Citrin; James B Mitchell
Journal:  Semin Oncol       Date:  2014-10-07       Impact factor: 4.929

Review 9.  Preclinical models in radiation oncology.

Authors:  Jenna Kahn; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-12-27       Impact factor: 3.481

10.  Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer.

Authors:  T T PUCK; P I MARCUS; S J CIECIURA
Journal:  J Exp Med       Date:  1956-02-01       Impact factor: 14.307
View more
  2 in total

1.  Screening and Validation of Molecular Targeted Radiosensitizers.

Authors:  Henning Willers; Xiao Pan; Nathalie Borgeaud; Irina Korovina; Lydia Koi; Regina Egan; Patricia Greninger; Aliza Rosenkranz; Jong Kung; Andrew S Liss; Leslie A Parsels; Meredith A Morgan; Theodore S Lawrence; Steven H Lin; Theodore S Hong; Beow Y Yeap; Lori J Wirth; Aaron N Hata; Christopher J Ott; Cyril H Benes; Michael Baumann; Mechthild Krause
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-31       Impact factor: 7.038

2.  Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.

Authors:  Chia-Hung Chien; Jian-Ying Chuang; Shun-Tai Yang; Wen-Bin Yang; Pin-Yuan Chen; Tsung-I Hsu; Chih-Yuan Huang; Wei-Lun Lo; Ka-Yen Yang; Ming-Sheng Liu; Jui-Mei Chu; Pei-Hsuan Chung; Jr-Jiun Liu; Shao-Wen Chou; Shang-Hung Chen; Kwang-Yu Chang
Journal:  J Biomed Sci       Date:  2019-10-19       Impact factor: 8.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.